you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Apr 16, 16:00
571.90 35.10 (6.54%)
Volume
AVERAGE VOLUME
5-Day
436,384
10-Day
314,425
30-Day
167,309
464,689
  • Prev. Close

    536.80

  • Open Price

    543.00

  • Bid Price (Qty.)

    568.00 (8)

  • Offer Price (Qty.)

    571.90 (300)

NSE Live

Apr 16, 15:59
571.90 34.95 (6.51%)
Volume
AVERAGE VOLUME
5-Day
8,098,368
10-Day
5,350,010
30-Day
2,767,030
11,468,653
  • Prev. Close

    536.95

  • Open Price

    539.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    571.90 (5932)

Financials

2020 2019 2018 2017 2016
Half Yearly Results of Glenmark Pharma (in Rs. Cr.) Mar '20 Sep '19 Mar '19 Sep '18 Mar '18  
Net Sales/Income from operations 3,424.02 3,197.86 3,130.66 3,000.48 2,965.57  
Other Operating Income -- 90.76 88.66 85.07 258.72  
Total Income From Operations 3,424.02 3,288.61 3,219.32 3,085.55 3,224.29  
EXPENDITURE  
Consumption of Raw Materials 1,165.02 1,086.96 791.44 794.42 1,053.72  
Purchase of Traded Goods 175.76 189.49 138.51 162.79 152.46  
Increase/Decrease in Stocks 38.37 10.40 314.40 157.41 4.28  
Power & Fuel -- -- -- -- --  
Employees Cost 506.52 565.81 456.31 513.67 487.73  
Depreciation 73.05 65.49 52.05 54.23 59.37  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 923.30 746.78 900.55 747.90 928.99  
P/L Before Other 542.01 623.69 566.05 655.15 537.74  
Other Income 345.78 261.01 83.75 391.87 81.53  
P/L Before Int. 887.79 884.69 649.80 1,047.01 619.27  
Interest 123.15 133.24 107.79 116.02 97.72  
P/L Before Exceptional Items & Tax 764.64 751.45 542.01 930.99 521.55  
Exceptional Items 18.55 -- -- 345.19 --  
P/L Before Tax 783.19 751.45 542.01 1,276.17 521.55  
Tax 88.48 91.62 91.30 238.58 105.92  
P/L After Tax from Ordinary Activities 694.71 659.84 450.71 1,037.59 415.63  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- 26.45 107.36 --  
Net Profit/(Loss) For the Period 694.71 659.84 477.16 1,144.95 415.63  
Equity Share Capital 28.22 28.22 28.22 28.22 28.22  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 24.62 23.38 -- 40.58 --  
Diluted EPS -- 23.38 -- 40.58 --  
EPS After Extra Ordinary  
Basic EPS. 24.62 23.38 -- 40.58 --  
Diluted EPS. -- 23.38 -- 40.58 --  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited